Abstract
In the current study, a simple method for the synthesis of 3-methyl-2-propyl-2H-[1,2,4]triazolo[4,3b][1,2,4,6]thiatriazine-1,1-dioxide (2) was carried out. In the presence of pyridine, a reaction between amidine (1) and sulfuryl chloride occurs. FTIR spectroscopy, 1H and 13C NMR, mass spectra, and elemental analysis were utilized in order to verify the structure of a novel synthetic molecule. The antibacterial activities of compound (2) were tested against eight pathogenic bacteria and the minimum inhibitory concentration as well as minimum bactericidal concentration were determined. Moreover, the possible antibiofilm effect of compound (2) was evaluated. Molecular docking was investigated to determine the interaction between compound (2) and eight crystal structures of bacterial and yeast proteins associated with virulence activity and antimicrobial resistance. Our results showed that the new 3-methyl-2-propyl-2H-[1,2,4]triazolo[4,3b][1,2,4,6]thiatriazine-1,1-dioxide (2) compound has a moderate antibacterial activity toward the selected pathogenic bacteria. The obtained MICs varied from 32 to 512 µg/mL being the lowest values attributed to Staphylococcus epidermidis ATCC 14990 and Streptococcus mutans ATCC 25175 (MIC = 32 µg/mL).We noted also that heterocyclic compound (2) may inhibit bacterial biofilm formation at concentration depend manner with a lowest value obtained against S.mutans ATCC 25175 (BIC50 = 490 µg/mL). Molecular docking showed a promising inhibitory activity of compound (2) on TetM-mediated tetracycline resistance (3J25) and Staphylococcus aureus gyrase (3G7B) with lower binding energy compared to the other target proteins.
KEY WORDS: Synthesis, Thiatriazine-1,1-dioxide, Antibacterial, Antibiofilm, Molecular docking
Bull. Chem. Soc. Ethiop. 2022, 36(1), 109-117.
DOI: https://dx.doi.org/10.4314/bcse.v36i1.10